How much can you eat on tirzepatide or semaglutide?
The US and EU weight-loss labels we checked set no portion size or calorie number for tirzepatide (Mounjaro, Zepbound) or semaglutide (Ozempic, Wegovy). They pair the medicine with a reduced-calorie diet. Both medicines lower hunger and slow stomach emptying. A 2025 US nutrition advisory suggests small meals every 3–4 hours, protein first, and avoiding large or fatty meals.
Do the labels set how much you can eat?
The US and EU weight-loss labels we checked give no portion size or calorie limit, and pair each medicine with a reduced-calorie diet.1234
The US Zepbound and Wegovy labels say to use the medicine with a reduced-calorie diet and more physical activity. Their dosing sections give no calorie figure.12 The EU Mounjaro and Wegovy product information (SmPCs) call each medicine an add-on to the same diet and activity.34
In the main US Zepbound weight trials, everyone was taught a diet of about 500 kcal a day below their needs. They were also advised to be active for at least 150 minutes a week.1
Why do smaller portions fill you up?
Both medicines lower hunger and raise fullness, and both slow how fast food leaves the stomach, according to their labels.1234
The EU Mounjaro SmPC says tirzepatide reduces how much people eat by increasing fullness and decreasing hunger.3 The EU Wegovy SmPC says the same of semaglutide.4
The EU Wegovy SmPC reports an early trial with a meal where people ate as much as they wanted. After 20 weeks, they ate 35% less on semaglutide than on placebo.4 Both EU SmPCs also say the medicines lower the preference for high-fat food.34
The US Zepbound label says the slowing of stomach emptying (gastric emptying) is largest after the first dose and lessens over time.1 The US Wegovy label says semaglutide slows it too.2
What happens if you eat past fullness?
Stomach side effects are common on these medicines, and the 2025 advisory says vomiting is more likely after large meals.15
In US Zepbound weight trials, nausea affected 25–29% of people, against 8% on placebo. Vomiting affected 8–13% against 2%, and burping 4–5% against 1%.1
The label says most nausea, vomiting and diarrhoea came during dose increases and eased over time.1 The advisory says avoiding large or high-fat meals can help.5
How should you eat when your appetite is small?
The 2025 advisory suggests a small breakfast, then small meals every 3–4 hours at regular times, with protein-rich food eaten first.5
It warns that people on these medicines may fast without meaning to, because they are not hungry. Long gaps without enough protein or variety can leave nutrition short.5
It gives 0.8 g of protein per kg of body weight a day as the general adult allowance. It notes that 1.2–1.6 g/kg has been proposed during weight loss.5 For a 90 kg person, that is 72 g a day, or 108–144 g.5
The advisory says protein shakes, bars and fortified foods help some people reach their targets. It lists portion control among the help a registered dietitian can give.5 The US Wegovy Medication Guide says drinking fluids lowers the chance of dehydration from vomiting or diarrhoea.2
What do people on GLP-1 medicines report about how much they eat?
From public patient forums: 21 Reddit threads in r/Zepbound, r/Semaglutide, r/WegovyWeightLoss, r/mounjaroaustralia, r/Mounjaro and r/Ozempic, read from October 2025 to October 2026. Personal reports, not medical evidence.
What people describe
- Matches the label Many say they can no longer finish their old meals, and often estimate they manage about half. The EU SmPCs say both medicines reduce how much people eat.34
- Matches the advisory Many say eating enough became the harder problem. They feel full after a few bites, are rarely hungry or forget to eat. The advisory notes that people may fast without meaning to.5
- Matches the label Many say eating past fullness brought hours of discomfort, nausea, bloating, burping or vomiting. The US Zepbound label lists nausea, vomiting and burping, and the advisory links vomiting to large meals.15
- Matches the advisory Several say fatty, greasy or sugary food sits badly, even in small amounts. The advisory says avoiding large or high-fat meals can help.5
Advice people share
- Matches the advisory Many advise eating protein first, so it gets eaten even without appetite.5
- Matches the advisory Many eat small amounts every 2–4 hours, hungry or not, though several long-term users say three normal meals work. The advisory suggests small meals every 3–4 hours at regular times.5
- Matches the advisory Many recommend a registered dietitian, ideally one who knows these medicines. The advisory lists portion control among the help a dietitian can give.5
- Label says otherwise A few posts treat very low intake as normal, or seek doses that badly suppress appetite. The advisory warns that long gaps without enough protein can leave nutrition short. The US Zepbound label allows a lower maintenance dose if one is not tolerated.15
In your country
How these medicines affect appetite is the same everywhere, but the brands sold and the labels we could open differ by country.
Australia
Sold as: Tirzepatide: Mounjaro. Semaglutide injection, weight: Wegovy. Semaglutide injection, diabetes: Ozempic. Semaglutide tablets, weight: none (Wegovy pill treated as not approved). Semaglutide tablets, diabetes: Rybelsus approved; whether supplied not confirmed.
Label: We did not open Australia’s Product Information for this page, so it relies on the US labels and the EU SmPCs.
Emergency number: 000
Life on a GLP-1 in Australia: eating, exercise and injections
Canada
Sold as: Tirzepatide: Mounjaro, Mounjaro KwikPen, Zepbound. Semaglutide injection, weight: Wegovy. Semaglutide injection, diabetes: Ozempic; Semaglutide Injection (Dr. Reddy’s; shortage reported Jul 2026, lots recalled Aug 2026); Apo-Semaglutide (one lot recalled Aug 2026). Semaglutide tablets, weight: none (no oral Wegovy in Health Canada’s drug database). Semaglutide tablets, diabetes: Rybelsus. Semaglutide approved but not marketed: Sevmia, Poviztra, Plosbrio, Aspen-Semaglutide, Semaglutide Injection (Aspen), Sandoz Semaglutide.
Label: We did not open Canada’s Product Monographs for this page, so it relies on the US labels and the EU SmPCs.
Emergency number: 911
France
Sold as: Tirzepatide: Mounjaro. Semaglutide injection, weight: Wegovy. Semaglutide injection, diabetes: Ozempic. Semaglutide tablets, weight: none (Wegovy pill not sold in France). Semaglutide tablets, diabetes: none found (Rybelsus not in France’s medicines database).
Label: The answer above applies.
Emergency number: 15 or 112
Germany
Sold as: Tirzepatide: Mounjaro. Semaglutide injection, weight: Wegovy, including 7.2 mg. Semaglutide injection, diabetes: Ozempic. Semaglutide tablets, weight: Wegovy Tablette. Semaglutide tablets, diabetes: Rybelsus.
Label: The answer above applies.
Emergency number: 112
India
Sold as: Tirzepatide: Mounjaro, Yurpeak. Semaglutide injection, weight: Wegovy; Poviztra; Noveltreat. Semaglutide injection, diabetes: Ozempic; Obeda (Dr Reddy’s; recalled Jul 2026 over an active-ingredient impurity; on 23 Oct 2026 the company said it planned to relaunch in Nov; resumption not confirmed at 8 Nov 2026; distributors told Reuters it may be discontinued); Sematrinity; GLIPIQ; Semalix (batches recalled Jul 2026); Semanat; Semafull. Semaglutide injection, diabetes and weight: Semaglyn; Mashema; Alterme; Semasize; Obesema; Hepaglide. Semaglutide, diabetes and weight (form not confirmed): Obeda Pro; Obeda Plus (Dr Reddy’s, made by Hetero Labs; in the market from late Jul 2026). Semaglutide injection, use not confirmed: Semanext; Livarise; Sundae. Semaglutide, form and use not confirmed: Samakind; Usema (batches recalled). Semaglutide tablets, weight: not confirmed. Semaglutide tablets, diabetes: Rybelsus; Sembolic; Obeda (tablets not part of the Jul 2026 recall).
Label: We did not open an Indian label for this page, so it relies on the US labels and the EU SmPCs.
Emergency number: 112
Saudi Arabia
Sold as: Tirzepatide: Mounjaro, Mounjaro KwikPen. Semaglutide injection, weight: Wegovy. Semaglutide injection, diabetes: Ozempic; Tasylev; Lugyda; Glucentra. Semaglutide tablets, weight: none (Wegovy pill not registered). Semaglutide tablets, diabetes: Rybelsus.
Label: We did not open a Saudi label for this page, so it relies on the US labels and the EU SmPCs.
Emergency number: 997 or 911
United Arab Emirates
Sold as: Tirzepatide: Mounjaro. Semaglutide injection, weight: Wegovy. Semaglutide injection, diabetes: Ozempic. Semaglutide tablets, weight: Wegovy pill. Semaglutide tablets, diabetes: Rybelsus.
Label: We did not open a UAE label for this page, so it relies on the US labels and the EU SmPCs.
Emergency number: 998 for an ambulance, or 999
United Kingdom
Sold as: Tirzepatide: Mounjaro. Semaglutide injection, weight: Wegovy, including 7.2 mg. Semaglutide injection, diabetes: Ozempic. Semaglutide tablets, weight: Wegovy tablets (authorised 11 Jun 2026; retail sale not confirmed). Semaglutide tablets, diabetes: Rybelsus.
Label: We did not open the UK SmPCs for this page, so it relies on the US labels and the EU SmPCs.
Emergency number: 999
United States
Sold as: Tirzepatide: Zepbound, Mounjaro. Semaglutide injection, weight: Wegovy, including Wegovy HD 7.2 mg. Semaglutide injection, diabetes: Ozempic. Semaglutide tablets, weight: Wegovy pill. Semaglutide tablets, diabetes: Ozempic tablets; Rybelsus (being discontinued).
Label: The answer above applies. It uses the US Zepbound and Wegovy labels; we did not open the US Mounjaro or Ozempic labels.
Emergency number: 911
Contact your prescriber or a doctor right away if you have nausea, vomiting or diarrhoea that does not go away. The US Wegovy Medication Guide also says to stop the medicine and call right away for severe stomach-area pain that will not go away, which can signal an inflamed pancreas (pancreatitis).2
Read the full picture
Related questions
Sources
- US Zepbound (tirzepatide) prescribing information. Eli Lilly
- US Wegovy (semaglutide) prescribing information and Medication Guide. DailyMed
- EU Mounjaro (tirzepatide) product information (SmPC). European Medicines Agency
- EU Wegovy (semaglutide) product information (SmPC). European Medicines Agency
- Mozaffarian D, et al. Nutritional priorities to support GLP-1 therapy for obesity: a joint advisory from the American College of Lifestyle Medicine, the American Society for Nutrition, the Obesity Medicine Association and The Obesity Society. Obesity (Silver Spring). 2025;33(8):1475–1503. Europe PMC full text
- MedlinePlus, US National Library of Medicine. Recognizing medical emergencies, giving the American College of Emergency Physicians’ warning signs. medlineplus.gov
Last checked Nov 16, 2026 · Next review due Nov 16, 2027 · Report an error
How this answer was made. Written by the GLP Guidebook team from the sources above, all checked on Nov 16, 2026. The “What people report” section summarises public patient forum posts we read; it is not medical evidence, and we never pass on advice that goes against the label. It’s general information, not medical advice. Talk to a doctor, pharmacist or other licensed prescriber before starting, stopping or changing any medicine. In an emergency, call your local emergency number. How we write